RBOT vs. LAKE, CLGN, APT, NTRB, MLSS, COCH, LFWD, POAI, HSCS, and NAOV
Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Lakeland Industries (LAKE), CollPlant Biotechnologies (CLGN), Alpha Pro Tech (APT), Nutriband (NTRB), Milestone Scientific (MLSS), Envoy Medical (COCH), ReWalk Robotics (LFWD), Predictive Oncology (POAI), Heart Test Laboratories (HSCS), and NanoVibronix (NAOV). These companies are all part of the "surgical appliances & supplies" industry.
Vicarious Surgical (NYSE:RBOT) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk, community ranking and dividends.
Vicarious Surgical has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, Lakeland Industries has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500.
Lakeland Industries has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.
In the previous week, Lakeland Industries had 4 more articles in the media than Vicarious Surgical. MarketBeat recorded 8 mentions for Lakeland Industries and 4 mentions for Vicarious Surgical. Lakeland Industries' average media sentiment score of 0.66 beat Vicarious Surgical's score of -0.35 indicating that Lakeland Industries is being referred to more favorably in the news media.
Lakeland Industries received 191 more outperform votes than Vicarious Surgical when rated by MarketBeat users. Likewise, 62.38% of users gave Lakeland Industries an outperform vote while only 38.10% of users gave Vicarious Surgical an outperform vote.
Lakeland Industries has a net margin of 4.33% compared to Vicarious Surgical's net margin of 0.00%. Lakeland Industries' return on equity of 6.63% beat Vicarious Surgical's return on equity.
47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are held by institutional investors. 11.7% of Vicarious Surgical shares are held by company insiders. Comparatively, 4.2% of Lakeland Industries shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Vicarious Surgical presently has a consensus price target of $0.67, suggesting a potential upside of 112.99%. Lakeland Industries has a consensus price target of $22.00, suggesting a potential upside of 21.68%. Given Vicarious Surgical's higher probable upside, equities research analysts clearly believe Vicarious Surgical is more favorable than Lakeland Industries.
Summary
Lakeland Industries beats Vicarious Surgical on 14 of the 17 factors compared between the two stocks.
Get Vicarious Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vicarious Surgical Competitors List
Related Companies and Tools
